ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Near infrared light activation of an injectable whole-cell cancer vaccine for cancer immunoprophylaxis and immunotherapy

Wang, Fei; Gao, Junbin; Wang, Shuanghu; Jiang, Jiamiao; Ye, Yicheng; Ou, Juanfeng; Liu, Shuwen*; Peng, Fei*; Tu, Yingfeng*南方医科大学; 中山大学
Biomaterials Science2021-6-7DOI: 10.1039/d1bm00542a
6被引9阅读
引用收藏
分享

摘要

Cancer vaccines play a key role in the prevention and treatment of early and recurrent tumors. Although they have been widely studied during the past few decades, designing an efficient and economical cancer vaccine is still challenging. Here, we propose an injectable live cell cancer vaccine (InLCCV) using live tumor cells as immunogenic sources for cancer immunoprophylaxis and immunotherapy. InLCCV is fabricated by loading live mouse breast cancer cells (4T1 cells), gold nanorods (GNRs), and super-low-dose lipopolysaccharide (LPS) into a biocompatible Pluronic F127 in situ hydrogel matrix. After in situ inactivation by the photothermal effect of GNRs upon near-infrared (NIR) laser irradiation, immunogenic cell death (ICD) of 4T1 cells is induced and tumor-associated antigens (TAAs) together with loaded LPS are released subsequently. Therefore, dendritic cells and macrophages are activated accordingly, further stimulating the systemic anti-tumor immune response. After vaccinating with InLCCV, the tumor-free percentage of the mice is 60% and the survival rate during the observation period reaches up to 80%. For lung metastasis, the metastatic foci are 3.9-fold less than those of the control group. The as-developed InLCCV shows much promise as a potential platform for breast cancer immunoprophylaxis and immunotherapy.

学科与关键词

关键词
THERAPYSTAGEHYPERTHERMIAIMPROVEDEATH
相关
加载中…
  • In situ photothermal nano-vaccine based on tumor cell membrane-coated black phosphorus-Au for photo-immunotherapy of metastatic breast tumors
    Huang, Deqiu; Wu, Tong; Lan, Siyuan; Liu, Chengkuan; Guo, Zhouyi*; Zhang, Wen*Biomaterials, 2022, 289: 121808.被引 12
  • An amphiphilic dendrimer as a light-activable immunological adjuvant for in situ cancer vaccination
    Wang, Yongchao; Gong, Ningqiang; Ma, Chi; Zhang, Yuxuan; Tan, Hong; Qing, Guangchao; Zhang, Jimei; Wang, Yufei; Wang, Jinjin; Chen, Shizhu; Li, Xianlei; Ni, Qiankun; Yuan, Yuan; Gan, Yaling; Chen, Junge; Li, Fangzhou; Zhang, Jinchao; Ou, Caiwen; Zhao, Yongxiang; Liu, Xiaoxuan; Liang, Xing-JieNature Communications, 2021, 12(1): 4964.被引 43
  • Laser-Activatable In Situ Vaccine Enhances Cancer-Immunity Cycle
    Wang, Zhenyu; You, Tingting; Su, Qianyi; Deng, Wenjia; Li, Jiabao; Hu, Saixiang; Shi, Shengjun; Zou, Zhaowei*; Xiao, Jisheng*; Duan, Xiaopin*Advanced Materials, 2023, 35(52).
查看全部 →

发表信息

论文状态
公开发表
期刊
Biomaterials Science
发表日期
2021-06-07
卷期
第 9 卷, 第 11 期
页码
3945-3953
DOI
10.1039/d1bm00542a
语言
ENGLISH
期刊收录
NSL
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [31800835, 21805318, 51973241]; Natural Science Foundation of Guangdong Province [2018A030313521, 2018B030306007]; Pearl Youth Scholar Funded Scheme

作者

  • W

    Wang, Fei (第一作者)

    new · southern med univ

  • G

    Gao, Junbin

    new · southern med univ

查看全部 9 位作者收起作者
  • W

    Wang, Shuanghu

    new · southern med univ

  • J

    Jiang, Jiamiao

    new · southern med univ

  • Y

    Ye, Yicheng

    new · southern med univ

  • O

    Ou, Juanfeng

    new · southern med univ

  • L

    Liu, Shuwen (通讯)

    new · southern med univ

  • P

    Peng, Fei (通讯)

    sun yat sen univ

  • T

    Tu, Yingfeng (通讯)

    new · southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417